{"id":34290,"date":"2025-12-23T17:34:35","date_gmt":"2025-12-23T16:34:35","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&#038;p=34290"},"modified":"2026-04-12T12:06:15","modified_gmt":"2026-04-12T10:06:15","slug":"slu-pp-332","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/slu-pp-332\/","title":{"rendered":"SLU-PP-332 500 mcg 60 kapsl\u00ed"},"content":{"rendered":"<div data-elementor-type=\"product-post\" data-elementor-id=\"34290\" class=\"elementor elementor-34290\" data-elementor-post-type=\"product\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0a060c4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0a060c4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-10a03f2\" data-id=\"10a03f2\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8d55ed4 elementor-widget elementor-widget-text-editor\" data-id=\"8d55ed4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 data-start=\"583\" data-end=\"640\"><strong data-start=\"586\" data-end=\"640\">SLU-PP-332 - co to je a jak to funguje<\/strong><\/h2><p data-start=\"642\" data-end=\"1270\">SLU-PP-332 je <strong data-start=\"656\" data-end=\"728\">experiment\u00e1ln\u00ed agonista receptoru pro estrogen (ERR)<\/strong> - skupina nukle\u00e1rn\u00edch jadern\u00fdch receptor\u016f, kter\u00e9 se pod\u00edlej\u00ed na regulaci <strong data-start=\"799\" data-end=\"876\">energetick\u00fd metabolismus, funkce mitochondri\u00ed a spot\u0159eba tuk\u016f.<\/strong>. L\u00e1tka je klasifikov\u00e1na jako <strong data-start=\"916\" data-end=\"938\">\u201emimetick\u00e9 cvi\u010den\u00ed\u201d<\/strong>, farmakologick\u00e1 slou\u010denina, kter\u00e1 v preklinick\u00fdch modelech aktivuje podobn\u00e9 metabolick\u00e9 dr\u00e1hy jako intenzivn\u00ed fyzick\u00e1 aktivita, co\u017e vede k <strong data-start=\"1090\" data-end=\"1231\">zv\u00fd\u0161en\u00e1 exprese gen\u016f souvisej\u00edc\u00edch s oxidac\u00ed mastn\u00fdch kyselin, mitochondri\u00e1ln\u00ed biogenez\u00ed a vytrvalostn\u00ed kapacitou sval\u016f.<\/strong>.\u00a0<\/p><p data-start=\"1272\" data-end=\"1793\">Mechanicky funguje SLU-PP-332 tak, \u017ee <strong data-start=\"1312\" data-end=\"1357\">vazba na receptory ERR\u03b1, ERR\u03b2 a ERR\u03b3.<\/strong>, s nejvy\u0161\u0161\u00ed aktivitou v\u016f\u010di ERR\u03b1, kter\u00fd stimuluje intracelul\u00e1rn\u00ed dr\u00e1hy reguluj\u00edc\u00ed mitochondri\u00e1ln\u00ed metabolismus a expresi gen\u016f souvisej\u00edc\u00edch s aerobn\u00ed adaptac\u00ed sval\u016f. U aktivovan\u00fdch ERR doch\u00e1z\u00ed ke zv\u00fd\u0161en\u00ed exprese protein\u016f zapojen\u00fdch do <strong data-start=\"1604\" data-end=\"1681\">oxidativn\u00ed fosforylace, beta-oxidace lipid\u016f a transport gluk\u00f3zy.<\/strong>, co\u017e se podob\u00e1 metabolick\u00fdm adaptac\u00edm pozorovan\u00fdm po intenzivn\u00edm cvi\u010den\u00ed.<\/p><p data-start=\"1272\" data-end=\"1793\"><a href=\"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/tesofensin\/\">Pod\u00edvejte se tak\u00e9 na Tesofensine 500mcg\/30caps<\/a><\/p><hr data-start=\"1795\" data-end=\"1798\" \/><h2 data-start=\"158\" data-end=\"191\">SLU PP 332 a hubnut\u00ed<\/h2><p data-start=\"193\" data-end=\"660\">Na z\u00e1klad\u011b dostupn\u00fdch preklinick\u00fdch studi\u00ed nebyl p\u0159\u00edpravek SLU-PP-332 p\u0159\u00edmo vyvinut jako klasick\u00fd prost\u0159edek pro sni\u017eov\u00e1n\u00ed hmotnosti, ale jeho mechanismus \u00fa\u010dinku nazna\u010duje, \u017ee by mohl b\u00fdt pou\u017eit jako <strong data-start=\"371\" data-end=\"433\">nep\u0159\u00edm\u00fd potenci\u00e1l ovlivnit energetickou bilanci organismu.<\/strong>. Aktivac\u00ed receptor\u016f ERR a pos\u00edlen\u00edm metabolick\u00fdch drah souvisej\u00edc\u00edch s funkc\u00ed mitochondri\u00ed a oxidac\u00ed mastn\u00fdch kyselin vede tato slou\u010denina k... <strong data-start=\"600\" data-end=\"659\">zv\u00fd\u0161en\u00fd v\u00fddej energie ve svalov\u00e9 tk\u00e1ni<\/strong>.<\/p><p data-start=\"662\" data-end=\"1088\">Na zv\u00ed\u0159ec\u00edch modelech bylo pozorov\u00e1no zlep\u0161en\u00ed metabolick\u00fdch parametr\u016f, zv\u00fd\u0161en\u00e1 spot\u0159eba energie a zm\u011bny v profilu svalov\u00fdch vl\u00e1ken sm\u011brem k aerobn\u011bj\u0161\u00edmu fenotypu, co\u017e je p\u0159\u00edzniv\u00e9. <strong data-start=\"852\" data-end=\"904\">lep\u0161\u00ed vyu\u017eit\u00ed energetick\u00fdch substr\u00e1t\u016f<\/strong>, v\u010detn\u011b lipid\u016f. Takov\u00e9 metabolick\u00e9 adaptace mohou experiment\u00e1ln\u011b sn\u00ed\u017eit metabolick\u00e9 poruchy podporuj\u00edc\u00ed obezitu a nep\u0159\u00edmo ovlivnit kontrolu hmotnosti.<\/p><p data-start=\"1090\" data-end=\"1513\">Je v\u0161ak t\u0159eba zd\u016fraznit, \u017ee <strong data-start=\"1119\" data-end=\"1195\">\u00dabytek hmotnosti nebyl prim\u00e1rn\u00edm c\u00edlov\u00fdm parametrem studie SLU-PP-332.<\/strong>, a v\u0161echna pozorov\u00e1n\u00ed se t\u00fdkaj\u00ed pouze preklinick\u00fdch model\u016f. Nedostatek klinick\u00fdch \u00fadaj\u016f znemo\u017e\u0148uje posoudit \u00fa\u010dinnost a bezpe\u010dnost slou\u010deniny v souvislosti se sni\u017eov\u00e1n\u00edm hmotnosti u lid\u00ed, tak\u017ee potenci\u00e1ln\u00ed \u00fa\u010dinek SLU-PP-332 na sn\u00ed\u017een\u00ed hmotnosti z\u016fst\u00e1v\u00e1 ve stadiu v\u00fdzkumn\u00fdch hypot\u00e9z a vy\u017eaduje dal\u0161\u00ed klinick\u00e9 studie.<\/p><hr data-start=\"1795\" data-end=\"1798\" \/><h2 data-start=\"1800\" data-end=\"1845\"><strong data-start=\"1803\" data-end=\"1845\">SLU-PP-332 - Stav studie a d\u00e1vkov\u00e1n\u00ed<\/strong><\/h2><p data-start=\"1847\" data-end=\"2188\">SLU-PP-332 z\u016fst\u00e1v\u00e1 na <strong data-start=\"1871\" data-end=\"1904\">f\u00e1ze p\u0159edklinick\u00fdch studi\u00ed<\/strong>. Nebyly provedeny \u017e\u00e1dn\u00e9 klinick\u00e9 studie na lidech a informace o d\u00e1vkov\u00e1n\u00ed se t\u00fdkaj\u00ed pouze zv\u00ed\u0159ec\u00edch model\u016f, p\u0159edev\u0161\u00edm my\u0161\u00ed. Slou\u010denina nem\u00e1 schv\u00e1len\u00e9 terapeutick\u00e9 pokyny ani klinick\u00e9 d\u00e1vkov\u00e1n\u00ed u lid\u00ed.<\/p><p data-start=\"2190\" data-end=\"2450\">V preklinick\u00fdch modelech byly pou\u017eity r\u016fzn\u00e9 d\u00e1vkovac\u00ed re\u017eimy, nej\u010dast\u011bji od <strong data-start=\"2270\" data-end=\"2294\">30 mg\/kg a\u017e 50 mg\/kg<\/strong> \u00fastn\u011b, aby <strong data-start=\"2333\" data-end=\"2411\">zkoum\u00e1n\u00ed metabolick\u00fdch \u00fa\u010dink\u016f, svalov\u00fdch adaptac\u00ed a \u201emimetick\u00e9ho p\u016fsoben\u00ed p\u0159i cvi\u010den\u00ed\u201d.\u201d<\/strong>.<\/p><hr data-start=\"2452\" data-end=\"2455\" \/><h2 data-start=\"2457\" data-end=\"2517\"><strong data-start=\"2460\" data-end=\"2517\">SLU-PP-332 - metabolick\u00e9 a \u201ecvi\u010den\u00ed mimetick\u00e9\u201d \u00fa\u010dinky\u201d<\/strong><\/h2><p data-start=\"2519\" data-end=\"2663\">P\u0159edklinick\u00e9 studie uk\u00e1zaly, \u017ee SLU-PP-332 aktivuje <strong data-start=\"2575\" data-end=\"2649\">genetick\u00fd program podobn\u00fd programu vyvolan\u00e9mu aerobn\u00edm tr\u00e9ninkem.<\/strong>, co\u017e m\u00e1 za n\u00e1sledek:<\/p><ul><li data-start=\"2667\" data-end=\"2881\">Zv\u00fd\u0161en\u00ed <strong data-start=\"2680\" data-end=\"2714\">oxidace mastn\u00fdch kyselin<\/strong> a metabolick\u00e9ho vyu\u017eit\u00ed energie ve svalech, v\u010detn\u011b exprese gen\u016f jako Pdk4 a Ddit4 spojen\u00fdch s metabolickou adaptac\u00ed.<\/li><li data-start=\"2884\" data-end=\"3046\">Zm\u011bna fenotypu svalov\u00fdch vl\u00e1ken sm\u011brem k aerobn\u011bj\u0161\u00edmu (oxida\u010dn\u00ed typ IIa), kter\u00e1 je spojena se zlep\u0161en\u00edm vytrvalostn\u00ed kapacity sval\u016f.<\/li><li data-start=\"3049\" data-end=\"3248\">Zv\u00fd\u0161en\u00fd po\u010det str\u00e1nek <strong data-start=\"3060\" data-end=\"3087\">fyzick\u00e1 vytrvalost<\/strong> a dobu b\u011bhu na zv\u00ed\u0159ec\u00edch modelech, co\u017e nazna\u010duje mo\u017enost zlep\u0161en\u00ed fyzick\u00fdch schopnost\u00ed i bez cvi\u010debn\u00edho tr\u00e9ninku.<\/li><\/ul><p data-start=\"3250\" data-end=\"3415\">Tyto \u010dinnosti se \u010dasto ozna\u010duj\u00ed jako <strong data-start=\"3288\" data-end=\"3341\">\u201efarmakologick\u00e9 napodobov\u00e1n\u00ed cvi\u010den\u00ed\u201d.\u201d<\/strong> (farmakologick\u00e9 mimetikum).<\/p><hr data-start=\"3417\" data-end=\"3420\" \/><h2 data-start=\"3422\" data-end=\"3456\"><strong data-start=\"3425\" data-end=\"3456\">SLU-PP-332 - Bezpe\u010dnost<\/strong><\/h2><p data-start=\"3458\" data-end=\"3963\">Proto\u017ee SLU-PP-332 nebyl klinicky studov\u00e1n u lid\u00ed, <strong data-start=\"3513\" data-end=\"3580\">bezpe\u010dnostn\u00ed profil v kontextu l\u00e9\u010dby lid\u00ed nen\u00ed zn\u00e1m.<\/strong>. V p\u0159edklinick\u00fdch modelech <strong data-start=\"3610\" data-end=\"3656\">nebyly hl\u00e1\u0161eny \u017e\u00e1dn\u00e9 akutn\u00ed toxick\u00e9 \u00fa\u010dinky<\/strong> ve studovan\u00fdch d\u00e1vk\u00e1ch a \u010dasech, ale jsou mo\u017en\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky souvisej\u00edc\u00ed s naru\u0161en\u00edm metabolick\u00e9 a mitochondri\u00e1ln\u00ed regulace. Potenci\u00e1ln\u00ed rizika se st\u00e1le zkoumaj\u00ed a zahrnuj\u00ed nap\u0159. <strong data-start=\"3840\" data-end=\"3922\">zm\u011bny enzymov\u00fdch parametr\u016f, funkce org\u00e1n\u016f a metabolick\u00e9 odezvy.<\/strong>.<\/p><hr data-start=\"3965\" data-end=\"3968\" \/><h2 data-start=\"3970\" data-end=\"4007\"><strong data-start=\"3973\" data-end=\"4007\">SLU-PP-332 - cena a dostupnost<\/strong><\/h2><p data-start=\"4009\" data-end=\"4470\">SLU-PP-332 <strong data-start=\"4020\" data-end=\"4067\">nen\u00ed registrov\u00e1n jako l\u00e9\u010div\u00fd p\u0159\u00edpravek<\/strong> a neexistuje jako l\u00e1tka dostupn\u00e1 v l\u00e9k\u00e1rn\u00e1ch. Jako experiment\u00e1ln\u00ed slou\u010denina a v\u00fdzkumn\u00e9 \u010dinidlo je n\u011bkdy nab\u00edzena v laboratorn\u00edm obchod\u011b. <strong data-start=\"4217\" data-end=\"4262\">v\u00fdhradn\u011b pro v\u011bdeck\u00e9 a v\u00fdzkumn\u00e9 \u00fa\u010dely<\/strong>, bez lidsk\u00e9ho souhlasu. Jeho dostupnost a cena z\u00e1vis\u00ed na dodavatel\u00edch \u010dinidel a jeho pou\u017eit\u00ed mimo v\u011bdeck\u00fd v\u00fdzkum. <strong data-start=\"4391\" data-end=\"4429\">se nedoporu\u010duje ani nen\u00ed leg\u00e1ln\u00ed.<\/strong>.<\/p><hr data-start=\"4472\" data-end=\"4475\" \/><h2 data-start=\"88\" data-end=\"116\">SLU-PP-332 - kde mohu koupit?<\/h2><p data-start=\"118\" data-end=\"489\" data-is-last-node=\"\" data-is-only-node=\"\">P\u0159\u00edpravek SLU-PP-332 nen\u00ed registrov\u00e1n jako l\u00e9\u010div\u00fd p\u0159\u00edpravek nebo dopln\u011bk stravy a nen\u00ed dostupn\u00fd v l\u00e9k\u00e1rn\u00e1ch. M\u016f\u017ee b\u00fdt nab\u00edzen pouze jako <strong data-start=\"269\" data-end=\"339\">\u010dinidlo pro v\u011bdeck\u00fd v\u00fdzkum a laboratorn\u00ed anal\u00fdzy<\/strong>, k dispozici od vybran\u00fdch dodavatel\u016f v oblasti v\u00fdzkumu a v\u00fdvoje. Tyto produkty nejsou ur\u010deny k pou\u017eit\u00ed u lid\u00ed ani k terapeutick\u00fdm \u00fa\u010del\u016fm.<\/p><hr data-start=\"4472\" data-end=\"4475\" \/><h2 data-start=\"4477\" data-end=\"4509\"><strong data-start=\"4480\" data-end=\"4509\">Funk\u010dn\u00ed shrnut\u00ed<\/strong><\/h2><p data-start=\"4511\" data-end=\"4631\">Stru\u010dn\u011b \u0159e\u010deno, SLU-PP-332 je <strong data-start=\"4536\" data-end=\"4612\">experiment\u00e1ln\u00ed mal\u00e1 molekula p\u016fsob\u00edc\u00ed jako agonista ERR<\/strong>, s potenci\u00e1lem:<\/p><ul><li data-start=\"4635\" data-end=\"4694\"><strong data-start=\"4635\" data-end=\"4661\">zv\u00fd\u0161en\u00ed imunity<\/strong> a metabolickou vytrvalost,<\/li><li data-start=\"4697\" data-end=\"4771\"><strong data-start=\"4697\" data-end=\"4734\">aktivace metabolick\u00fdch drah<\/strong> typick\u00e9 pro intenzivn\u00ed cvi\u010den\u00ed,<\/li><li data-start=\"4774\" data-end=\"4833\"><strong data-start=\"4774\" data-end=\"4830\">zlep\u0161uj\u00ed oxidaci tuk\u016f a funkci mitochondri\u00ed.<\/strong>,<\/li><li data-start=\"4836\" data-end=\"4927\">potenci\u00e1ln\u00ed dopad na <strong data-start=\"4860\" data-end=\"4926\">metabolick\u00e9 sign\u00e1ly spojen\u00e9 s obezitou a inzulinovou rezistenc\u00ed.<\/strong>,<\/li><\/ul><p data-start=\"4929\" data-end=\"5098\">nicm\u00e9n\u011b, v\u0161echno <strong data-start=\"4945\" data-end=\"4987\">vych\u00e1z\u00ed z preklinick\u00fdch \u00fadaj\u016f<\/strong> a p\u0159ed terapeutick\u00fdm hodnocen\u00edm u lid\u00ed vy\u017eaduje dal\u0161\u00ed klinick\u00e9 studie.<\/p><p data-start=\"4929\" data-end=\"5098\"><a href=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-34003 size-medium\" src=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-300x182.png\" alt=\"SLU-PP-332 ist ein experimenteller \u00d6strogen-verwandter Rezeptor (ERR)-Agonist.\" width=\"300\" height=\"182\" srcset=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-300x182.png 300w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-1024x623.png 1024w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-768x467.png 768w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-18x12.png 18w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-800x487.png 800w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542-64x39.png 64w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/12\/SLU-PP-332-e1766074600542.png 1085w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p><hr data-start=\"1923\" data-end=\"1926\" \/><p data-start=\"5105\" data-end=\"5146\"><strong>Zdroje \/ literatura pro SLU-PP-332:<\/strong><\/p><p data-start=\"5148\" data-end=\"5343\"><strong data-start=\"5151\" data-end=\"5168\">PubMed (2023)<\/strong> - Identifikace SLU-PP-332 jako pan-ERR agonisty s \u201emimetick\u00fdm\u201d \u00fa\u010dinkem p\u0159i cvi\u010den\u00ed ve svalech. <br data-start=\"5299\" data-end=\"5302\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36988910\" target=\"_new\" rel=\"noopener\" data-start=\"5302\" data-end=\"5343\">https:\/\/pubmed.ncbi.nlm.nih.gov\/36988910\/<\/a><\/p><p data-start=\"5345\" data-end=\"5531\"><strong data-start=\"5348\" data-end=\"5388\">PubMed \/ J Pharmacol Exp Ther (2024)<\/strong> - \u00fa\u010dinky agonist\u016f ERR na my\u0161\u00edch metabolick\u00fdch modelech. <br data-start=\"5487\" data-end=\"5490\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37739806\" target=\"_new\" rel=\"noopener\" data-start=\"5490\" data-end=\"5531\">https:\/\/pubmed.ncbi.nlm.nih.gov\/37739806\/<\/a><\/p><p data-start=\"5533\" data-end=\"5734\"><strong data-start=\"5536\" data-end=\"5567\">ACS Chemical Biology (2023)<\/strong> - Identifikace a molekul\u00e1rn\u00ed mechanismus p\u016fsoben\u00ed SLU-PP-332 proti receptor\u016fm ERR. <br data-start=\"5680\" data-end=\"5683\" \/><a class=\"decorated-link\" href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acschembio.2c00720\" target=\"_new\" rel=\"noopener\" data-start=\"5683\" data-end=\"5734\">https:\/\/pubs.acs.org\/doi\/10.1021\/acschembio.2c00720<\/a><\/p><p data-start=\"5736\" data-end=\"6027\"><strong data-start=\"5739\" data-end=\"5773\">Frontiers in Physiology (2025)<\/strong> - P\u0159ehled \u00falohy ERR a potenci\u00e1lu agonist\u016f, jako je SLU-PP-332, jako \u201emimetik cvi\u010den\u00ed\u201d v kontextu metabolismu a st\u00e1rnut\u00ed. <br data-start=\"5936\" data-end=\"5939\" \/><a class=\"decorated-link\" href=\"https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2025.1616693\/full\" target=\"_new\" rel=\"noopener\" data-start=\"5939\" data-end=\"6027\">https:\/\/www.frontiersin.org\/journals\/physiology\/articles\/10.3389\/fphys.2025.1616693\/full<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>SLU-PP-332 je nov\u00e1 molekula zn\u00e1m\u00e1 sv\u00fdmi \u00fa\u010dinky na svalov\u00fd metabolismus a v\u00fddej energie. Jej\u00ed \u00fa\u010dinek je zalo\u017een na aktivaci kl\u00ed\u010dov\u00fdch metabolick\u00fdch drah, co\u017e podporuje efektivn\u00ed vyu\u017eit\u00ed energie a kontrolu hmotnosti.<\/p>","protected":false},"featured_media":34003,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[130,135,15],"product_tag":[137],"class_list":{"0":"post-34290","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-kapsulkach-tabletkach","7":"product_cat-produkty-w-kapsulkach","8":"product_cat-laboratory-research","9":"product_tag-kapsulki","11":"first","12":"instock","13":"sale","14":"shipping-taxable","15":"purchasable","16":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/comments?post=34290"}],"version-history":[{"count":10,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34290\/revisions"}],"predecessor-version":[{"id":35355,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/34290\/revisions\/35355"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media\/34003"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media?parent=34290"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_brand?post=34290"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_cat?post=34290"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_tag?post=34290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}